Anny OrtizMay 31, 20228 min readPharmaceutical InequalitiesThe emerging therapeutic value of 5-MeO-DMT
Anny OrtizMay 10, 20228 min readPharmaceutical InequalitiesPsychedelics in the treatment of substance use disorders: the case of ibogaine
Jocelyn Szczepaniak-GilleceJul 13, 202110 min readGuest BloggersAddictions, Media, and Power: Jay Richard Kennedy and Mind Control
Michael BrownriggMar 1, 20217 min readMichael BrownriggHidden Addicts: The Elderly and the Opioid Epidemic
Brooks HudsonJan 31, 20206 min readBrooks HudsonPublic Relations Language Disguises How Drug Discourse Today Is More Successful
Jeremy MilloyJul 25, 20194 min readJeremy MilloyChipping Away: Opioids, Autowork, and the UAW Yesterday and Today
Jill McCorkelSep 18, 20184 min readGender and Critical Drug Studies: The Gendered Origins of Privatized Prison Drug Treatment
Marcus ChatfieldAug 4, 20167 min readMarcus ChatfieldThe State of the Art: The Malcolms’ Examination of Straight, Incorporated, TimelineEditor’s Note: This is the fifth in a five-part series from Marcus Chatfield, a regular contributor to Points. Here he offers a timeline...
Marcus ChatfieldJul 21, 20165 min readMarcus ChatfieldThe State of the Art: The Malcolms’ Examination of Straight, Incorporated, Part 4
Marcus ChatfieldJul 14, 20165 min readMarcus ChatfieldThe State of the Art: The Malcolms’ Examination of Straight, Incorporated, Part 3
Marcus ChatfieldJul 7, 20163 min readMarcus ChatfieldThe State of the Art: The Malcolms’ Examination of Straight, Incorporated, Part 2
